Safer chemsex: consideration of Shigella.

Manpreet Bains, Paul Crook, Nigel Field, Gwenda Hughes
Author Information
  1. Manpreet Bains: Public Health England. E-mail: manpreet.bains@phe.gov.uk.
  2. Paul Crook: Consultant Field Epidemiologist, Field Epidemiology London.
  3. Nigel Field: Consultant Clinical Epidemiologist, Department of HIV and STIs, National Infection Service, Public Health England.
  4. Gwenda Hughes: Consultant Scientist (Epidemiology) and Head of STI Section, Department of HIV and STIs, National Infection Service, Public Health England.

Abstract

No abstract text available.

References

  1. Euro Surveill. 2014;19(43). pii: 20946 [PMID: 25375900]
  2. Br J Gen Pract. 2016 Jan;66(642):4-5 [PMID: 26719455]
  3. Euro Surveill. 2015;20(15). pii: 21097 [PMID: 25953129]
  4. Sex Transm Infect. 2015 Dec;91(8):598-602 [PMID: 25921020]

MeSH Term

Anti-Bacterial Agents
Drug Resistance, Microbial
Dysentery, Bacillary
Escherichia coli
Humans
Safety
Sexual Behavior
Shigella
Shigella boydii
Shigella dysenteriae
Shigella flexneri
Shigella sonnei

Chemicals

Anti-Bacterial Agents

Word Cloud

Created with Highcharts 10.0.0Saferchemsex:considerationShigella

Similar Articles

Cited By